OBIO
Orchestra BioMed Holdings Inc.
6.00$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| 2.5% | – | 9.1% | 6.7% | 7.7% | 0.6% | |
| 97.5% | – | 90.9% | 93.3% | 92.3% | 99.4% | |
| 236.3% | – | 621.1% | 1,225.4% | 1,622.6% | 173.8% | |
| 190.0% | – | 397.2% | 734.0% | 907.2% | 80.4% | |
| 426.3% | – | 1,015.2% | 1,959.4% | 2,529.8% | 254.2% | |
| -328.8% | – | -924.3% | -1,866.2% | -2,437.5% | -154.7% | |
| – | – | – | – | – | 3.4% | |
| -374.5% | – | -951.3% | -1,779.7% | -2,313.3% | -157.4% | |
| 45.6% | – | -6.3% | 4.3% | – | – | |
| -374.5% | – | -951.3% | -1,779.7% | -2,313.3% | -157.4% | |
| -326.4% | – | -945.0% | -1,769.3% | -2,301.6% | -153.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.